CLINICAL FACTORS PREDISPOSING TO ACHIEVEMENT OF RBC TRANSFUSION INDEPENDENCEIN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES) WITHOUT DEL(5q) IN MDS-005 STUDY

被引：0

作者：

Santini, V. ^{[1
]}

Li, J. Shiansong ^{[2
]}

Swern, A. S. ^{[2
]}

Almeida, A. ^{[3
]}

Giagounidis, A. ^{[4
]}

Fu, T. ^{[2
]}

Sanna, A. ^{[1
]}

Hoenekopp, A. ^{[5
]}

Beach, C. L. ^{[2
]}

Skikne, B. ^{[2
]}

Fenaux, P. ^{[6
]}

机构：

[1] Univ Florence, AOU Careggi, Dipartimento Med Sperimentale & Clin, Florence, Italy

[2] Celgene Corp, Summit, NJ USA

[3] Inst Portugues Oncol Francisco Gentil, Dept Hematol, Lisbon, Portugal

[4] Marien Hosp, Hematol, Dusseldorf, Germany

[5] Celgene Int, Hematol & Oncol, Boudry, Switzerland

[6] Univ Paris 07, Hop St Louis, Serv Hematol Sr, Paris, France

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BEST2-B007

引用

页码：3 / 4

页数：2